ID - HIV Flashcards
Life expectancy of HIV +ve patient compared to -ve
8 years less (71 vs 79)
Which HIV patients should you treat with ART?
all
naming convention of HIV drugs
all integrase inhibitors end in: -gravir
Favoured combination of HIV drugs (class wise)
Integrase inhibitor + 2 NRTI
OR
Integrase inhibitor + 1 NRTI
If patient presents with new HIV and opportunistic infection what should you do re HIV meds
Start the HIV meds
2 caveats for delaying treatment:
- TB affecting the brain
- cryptococcal meningitis
(concerns regarding immune over-activation, inflammation and brain herniation)
Tenofovir forms and link
TAF - Tenofovir alafenamide
Prodrug of TDF converted to TDF intracellular
TDF - Tenofovir Disoproxil fumarate
AE Tenofovir (TDF)
renal disease, bone disease (more with TDF)
- less with TAF
Pharmacokinetic relation of tenofovir forms (TAF vs TDF)
Tenofovir alafenamide (TAF) Prodrug of TDF converted to TDF intracellular
TMP-SMX + pred
(Don’t treat CMV in HIV patients unless histological changes suggesting it’s pathogenic)
HIV drugs contra-indicated in pregnancy
all are fine
Abacavir AE
Hypersensitivity reaction ( 5-8%) if HLAB5701
zidovudine AE
anaemia, Lipodystrophy
Cardinal AIDS Defining Illnesses
- Kaposi Sarcoma
- CMV retinitis
- Disseminated Mycobacterium avium complex/Tuberculosis
- Pneumocystis pneumonia
- Oesophageal Candidiasis
- Toxoplasma encephalitis
- Chronic cryptosporidiosis / microsporidiosis
CD4 count that HIV patients tend to get opportunistic infections
typically < 200
Vaccine and HIV
don’t give live vaccines if CD4 < 200